Life expectancy for people with metastatic or metastasized lung cancer is low. The 5-year survival rate for small cell lung cancer is 3%, and 8% for non-small cell lung cancer (NSCLC). 25-30% of ...

A groundbreaking study has revealed a significant link between the frequency of chest X-ray referrals from GPs and earlier ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

Lung cancer screening with low-dose CT could have saved tens of thousands of lives — if only we'd listened to the data back ...

A study found a "significant" link between the frequency of chest X-ray referrals and improved survival rates for lung cancer ...

Lung Cancer Test Predicts Survival in Early Stages ... that found the drug AM-101 improves the effectiveness and survival rate of radiation ... Sep. 25, 2024 — Researchers have tested a ...

Feb. 25, 2025 — Our organs age at different rates, and a blood test determining ... The findings could significantly change the ... Lung Cancer Test Predicts Survival in Early Stages Better ...

Johnson & Johnson has produced the most convincing data to date that its combination of Rybrevant and Lazcluze could replace ...

First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

The New York State Senate has unanimously passed Senate Bill S. 2000, a significant step toward improving the early detection ...